Evidence map›Paper›PMID 23624627›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2013

Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

Stephen F Vatner, Misun Park, Lin Yan, Grace J Lee, Lo Lai, Kousaku Iwatsubo, Yoshihiro Ishikawa, Jeffrey Pessin, Dorothy E Vatner

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. 1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit.International journal of molecular sciences · 2024
    Article
  8. Review
  9. Compartmentalized cAMP signalling and control of cardiac rhythm.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Life (Basel, Switzerland) · 2021
    Article
  14. Redox Regulation of Lipid Mobilization in Adipose Tissues.Antioxidants (Basel, Switzerland) · 2021
    Review
  15. Effects of Whole-Body Adenylyl Cyclase 5 (International journal of molecular sciences · 2021
    Article
  16. Article
  17. Cross-Talk Between the Adenylyl Cyclase/cAMP Pathway and CaReviews of physiology, biochemistry and pharmacology · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Stephen F VatnerDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA. vatnersf@umdnj.edu
Misun Park
Lin Yan
Grace J Lee
Lo Lai
Kousaku Iwatsubo
Yoshihiro Ishikawa
Jeffrey Pessin
Dorothy E Vatner
Rutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · USAlbert Einstein College of Medicine · US

Funding

Molecular Mechanisms in Chronically Stunned MyocardiumP01HL069020 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2001 to 2014
$21.3M
Longevity and Stress ResistanceP01AG027211 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2007 to 2013
$10.3M
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATESR01HL033107 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1985 to 2011
$6.2M
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KOR01HL106511 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2011 to 2019
$3.8M
Intrinsic Vascular Smooth Muscle Cell StiffnessR01HL102472 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2010 to 2016
$2.5M
Adenylyl cyclase isoforms in hypertrophy and heart failureR01HL093481 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2009 to 2013
$2.3M
SFRP2, cell survival, and coronary vascular angiogenesisR01HL119464 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2013 to 2016
$1.8M
Rescue of Beta-Adrenergic Cardiomyopathy by Inhibition of Adenylyl CyclaseR01HL095888 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2009 to 2014
$1.7M
CARDIOVASCULAR CONTROL IN NORMAL AND DISEASE STATESR37HL033107 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1992 to 2001
$1.2M
NHLBI NIH HHS HL-033107NHLBI NIH HHS HL-069020NHLBI NIH HHS HL-093481NHLBI NIH HHS HL-095888NHLBI NIH HHS HL-106511NHLBI NIH HHS R01 HL093481NHLBI NIH HHS R01 HL102472NHLBI NIH HHS R01 HL106511NHLBI NIH HHS R01 HL119464NIA NIH HHS AG-027211
6 · The paper itself

Abstract

G protein-coupled receptor/adenylyl cyclase (AC)/cAMP signaling is crucial for all cellular responses to physiological and pathophysiological stimuli. There are nine isoforms of membrane-bound AC, with type 5 being one of the two major isoforms in the heart. Since the role of AC in the heart in regulating cAMP and acute changes in inotropic and chronotropic state are well known, this review will address our current understanding of the distinct regulatory role of the AC5 isoform in response to chronic stress. Transgenic overexpression of AC5 in cardiomyocytes of the heart (AC5-Tg) improves baseline cardiac function but impairs the ability of the heart to withstand stress. For example, chronic catecholamine stimulation induces cardiomyopathy, which is more severe in AC5-Tg mice, mediated through the AC5/sirtuin 1/forkhead box O3a pathway. Conversely, disrupting AC5, i.e., AC5 knockout, protects the heart from chronic catecholamine cardiomyopathy as well as the cardiomyopathies resulting from chronic pressure overload or aging. Moreover, AC5 knockout results in a 30% increase in a healthy life span, resembling the most widely studied model of longevity, i.e., calorie restriction. These two models of longevity share similar gene regulation in the heart, muscle, liver, and brain in that they are both protected against diabetes, obesity, and diabetic and aging cardiomyopathy. A pharmacological inhibitor of AC5 also provides protection against cardiac stress, diabetes, and obesity. Thus AC5 inhibition has novel, potential therapeutic applicability to several diseases not only in the heart but also in aging, diabetes, and obesity.

Indexed as

Adenylyl Cyclase InhibitorsAdenylyl CyclasesAnimalsCardiomyopathiesEnzyme InhibitorsHumansLongevityAdenylyl Cyclase InhibitorsAdenylyl Cyclasesadenylyl cyclase type VEnzyme InhibitorsAC5 inhibitoradenylyl cyclase type 5agingcardiomyopathymetabolism

Identifiers

PMID23624627
PMCPMC3727099
OpenAlexW2140897490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.